These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16107762)

  • 1. Roles of adaptor molecules in mast cell activation.
    Tkaczyk C; Iwaki S; Metcalfe DD; Gilfillan AM
    Chem Immunol Allergy; 2005; 87():43-58. PubMed ID: 16107762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.
    Kepley CL; Taghavi S; Mackay G; Zhu D; Morel PA; Zhang K; Ryan JJ; Satin LS; Zhang M; Pandolfi PP; Saxon A
    J Biol Chem; 2004 Aug; 279(34):35139-49. PubMed ID: 15151996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification mechanisms for the enhancement of antigen-mediated mast cell activation.
    Gilfillan AM; Peavy RD; Metcalfe DD
    Immunol Res; 2009; 43(1-3):15-24. PubMed ID: 18827981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of arachidonic acid analogs on FcepsilonRI-mediated activation of mast cells.
    Nakano N; Nakao A; Uchida T; Shirasaka N; Yoshizumi H; Okumura K; Tsuboi R; Ogawa H
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):19-28. PubMed ID: 16403671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human mast cells through the high affinity IgG receptor.
    Tkaczyk C; Okayama Y; Woolhiser MR; Hagaman DD; Gilfillan AM; Metcalfe DD
    Mol Immunol; 2002 Sep; 38(16-18):1289-93. PubMed ID: 12217397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release.
    Tkaczyk C; Okayama Y; Metcalfe DD; Gilfillan AM
    Int Arch Allergy Immunol; 2004 Mar; 133(3):305-15. PubMed ID: 15017113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
    Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
    Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling assemblies formed in mast cells activated via Fcepsilon receptor I dimers.
    Dráberová L; Lebduska P; Hálová I; Tolar P; Stokrová J; Tolarová H; Korb J; Dráber P
    Eur J Immunol; 2004 Aug; 34(8):2209-19. PubMed ID: 15259018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A BASH/SLP-76-related adaptor protein MIST/Clnk involved in IgE receptor-mediated mast cell degranulation.
    Goitsuka R; Kanazashi H; Sasanuma H; Fujimura Y; Hidaka Y; Tatsuno A; Ra C; Hayashi K; Kitamura D
    Int Immunol; 2000 Apr; 12(4):573-80. PubMed ID: 10744659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.
    Ott VL; Tamir I; Niki M; Pandolfi PP; Cambier JC
    J Immunol; 2002 May; 168(9):4430-9. PubMed ID: 11970986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of SLP-76 interaction with Gads inhibits dynamic clustering of SLP-76 and FcepsilonRI signaling in mast cells.
    Silverman MA; Shoag J; Wu J; Koretzky GA
    Mol Cell Biol; 2006 Mar; 26(5):1826-38. PubMed ID: 16479002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative signals from FcepsilonRI engagement attenuate mast cell functions.
    Molfetta R; Peruzzi G; Santoni A; Paolini R
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):219-29. PubMed ID: 17659377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation of adapter molecules in proximal signaling cascades during allergic inflammation.
    Kambayashi T; Larosa DF; Silverman MA; Koretzky GA
    Immunol Rev; 2009 Nov; 232(1):99-114. PubMed ID: 19909359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
    Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
    J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of mast cell activation through FcepsilonRI.
    Yamasaki S; Saito T
    Chem Immunol Allergy; 2005; 87():22-31. PubMed ID: 16107760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PH domain adaptor protein Bam32/DAPP1 functions in mast cells to restrain FcɛRI-induced calcium flux and granule release.
    Hou S; Pauls SD; Liu P; Marshall AJ
    Mol Immunol; 2010; 48(1-3):89-97. PubMed ID: 20956018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.
    Kuehn HS; Gilfillan AM
    Immunol Lett; 2007 Nov; 113(2):59-69. PubMed ID: 17919738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cbl family proteins: balancing FcεRI-mediated mast cell and basophil activation.
    Gasparrini F; Molfetta R; Santoni A; Paolini R
    Int Arch Allergy Immunol; 2011; 156(1):16-26. PubMed ID: 21447956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.